Masimo (MASI) Competitors $143.17 -2.55 (-1.75%) As of 02:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. AMN, VEEV, DXCM, PODD, STE, HOLX, BAX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include AMN Healthcare Services (AMN), Veeva Systems (VEEV), DexCom (DXCM), Insulet (PODD), STERIS (STE), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "medical" sector. Masimo vs. Its Competitors AMN Healthcare Services Veeva Systems DexCom Insulet STERIS Hologic Baxter International Globus Medical Teleflex Integer Masimo (NASDAQ:MASI) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations. Which has more risk and volatility, MASI or AMN? Masimo has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Does the media prefer MASI or AMN? In the previous week, Masimo had 1 more articles in the media than AMN Healthcare Services. MarketBeat recorded 21 mentions for Masimo and 20 mentions for AMN Healthcare Services. Masimo's average media sentiment score of 0.84 beat AMN Healthcare Services' score of 0.06 indicating that Masimo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 11 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals have more ownership in MASI or AMN? 86.0% of Masimo shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 16.9% of Masimo shares are owned by insiders. Comparatively, 0.9% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts recommend MASI or AMN? Masimo currently has a consensus target price of $194.60, suggesting a potential upside of 35.78%. AMN Healthcare Services has a consensus target price of $23.25, suggesting a potential upside of 24.33%. Given Masimo's stronger consensus rating and higher probable upside, equities analysts clearly believe Masimo is more favorable than AMN Healthcare Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00AMN Healthcare Services 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has higher earnings and valuation, MASI or AMN? AMN Healthcare Services has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMasimo$2.09B3.72-$304.90M-$8.52-16.82AMN Healthcare Services$2.98B0.24-$146.98M-$7.77-2.41 Is MASI or AMN more profitable? AMN Healthcare Services has a net margin of -10.75% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat AMN Healthcare Services' return on equity.Company Net Margins Return on Equity Return on Assets Masimo-24.85% 26.54% 11.49% AMN Healthcare Services -10.75%11.09%3.34% SummaryMasimo beats AMN Healthcare Services on 11 of the 17 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.78B$6.65B$5.72B$10.27BDividend YieldN/A1.21%5.72%4.60%P/E Ratio-16.8026.4475.7726.39Price / Sales3.72195.26493.51166.99Price / Cash23.0822.1825.8129.90Price / Book7.354.9512.856.30Net Income-$304.90M$176.38M$3.29B$270.30M7 Day Performance-3.24%4.73%0.37%1.98%1 Month Performance-6.86%7.16%4.74%6.16%1 Year Performance25.75%10.65%68.88%27.93% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.7735 of 5 stars$143.17-1.7%$194.60+35.9%+29.2%$7.77B$2.09B-16.785,600AMNAMN Healthcare Services4.4893 of 5 stars$20.97+0.6%$28.25+34.7%-61.4%$799.06M$2.98B-2.702,968Short Interest ↓VEEVVeeva Systems4.3827 of 5 stars$282.97+3.7%$301.48+6.5%+26.6%$44.74B$2.75B54.597,291Positive NewsDXCMDexCom4.9755 of 5 stars$78.00-3.1%$99.89+28.1%+8.7%$31.57B$4.03B54.1710,300Positive NewsPODDInsulet4.4825 of 5 stars$349.56+0.3%$335.12-4.1%+45.5%$24.53B$2.07B106.253,900Positive NewsSTESTERIS4.8927 of 5 stars$248.41+1.3%$273.50+10.1%+1.2%$24.16B$5.46B38.0417,787Positive NewsAnalyst UpgradeHigh Trading VolumeHOLXHologic4.9165 of 5 stars$66.54-0.3%$78.00+17.2%-21.4%$14.85B$4.03B27.617,063Positive NewsAnalyst DowngradeBAXBaxter International4.8429 of 5 stars$24.08-1.4%$30.11+25.1%-40.1%$12.54B$10.64B-80.2538,000News CoveragePositive NewsGMEDGlobus Medical4.6949 of 5 stars$59.37-2.0%$87.64+47.6%-16.6%$8.18B$2.52B22.835,300Positive NewsAnalyst UpgradeTFXTeleflex4.643 of 5 stars$130.20-0.4%$141.57+8.7%-48.9%$5.78B$3.05B30.6414,100Analyst DowngradeITGRInteger3.9628 of 5 stars$106.01-0.9%$140.25+32.3%-21.0%$3.75B$1.72B46.7011,000 Related Companies and Tools Related Companies AMN Healthcare Services Alternatives Veeva Systems Alternatives DexCom Alternatives Insulet Alternatives STERIS Alternatives Hologic Alternatives Baxter International Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
